Pharmacogenomics

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco + genomics) reflects it’s combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorption, distribution, metabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

    Related Conference of Pharmacogenomics

    May 10-11, 2019

    8th Asia Pacific Glycobiology Congress

    Tokyo, Japan
    May 17-18, 2019

    2nd International Conference on Computational Biology and Bioinformatics

    | Holiday Inn Singapore Atrium | Singapore
    July 11-12, 2019

    8th Glycobiology World Congress

    Zurich, Switzerland
    May 10-11, 2019

    4th International Conference on Enzymology & Molecular Biology

    | Radisson Hotel Narita | Tokyo, Japan
    October 07-08, 2019

    4th International Conference on Molecular Biology & Nucleic Acids

    Chicago, Illinois, USA

    Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in